Patents Assigned to SnIP Holdings, Inc.
  • Methods and therapies for treating inflammatory conditions with exposed collagen
    Patent number: 9623129
    Abstract: Compositions and methods for treating and imaging vulnerable plaque and other inflammatory conditions in a patient rely on the delivery of conversion electron-emitting sources and other radionuclides to regions of exposed collagen in the vasculature or other body lumens. The conversion electron-emitting sources or other radionuclides are coupled to a collagen-binding substance and administered to the vasculature or other body lumen to permit binding for imaging and/or therapeutic purposes.
    Type: Grant
    Filed: September 25, 2006
    Date of Patent: April 18, 2017
    Assignee: SnIP Holdings, Inc.
    Inventors: Gilbert R. Gonzales, Dale DeVore, Suresh Srivastava
  • Dosimetry implant for treating restenosis and hyperplasia
    Patent number: 8834338
    Abstract: The present invention discloses a method of selectively providing radiation dosimetry to a subject in need of such treatment. The radiation is applied by an implant comprising a body member and 117mSn electroplated at selected locations of the body member, emitting conversion electrons absorbed immediately adjacent selected locations while not affecting surrounding tissue outside of the immediately adjacent area.
    Type: Grant
    Filed: June 6, 2007
    Date of Patent: September 16, 2014
    Assignee: SnIP Holdings, Inc.
    Inventors: Suresh Srivastava, Gilbert R. Gonzales, Roger W. Howell, Wesley E. Bolch, Radoslav Adzic